Get access to our best features
Get access to our best features
Published

Weiss Ratings Reaffirms "Sell (E+)" Rating for 2seventy bio (NASDAQ:TSVT)

Summary by marketbeat.com
Weiss Ratings reissued a "sell (e+)" rating on shares of 2seventy bio in a research note on Saturday.
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics